Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0H0KP
|
||||
| Former ID |
DNC007806
|
||||
| Drug Name |
6-(4-(3-(benzylamino)propyl)phenoxy)nicotinamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528996] | ||
| Formula |
C22H23N3O2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CNCCCC2=CC=C(C=C2)OC3=NC=C(C=C3)C(=O)N
|
||||
| InChI |
1S/C22H23N3O2/c23-22(26)19-10-13-21(25-16-19)27-20-11-8-17(9-12-20)7-4-14-24-15-18-5-2-1-3-6-18/h1-3,5-6,8-13,16,24H,4,7,14-15H2,(H2,23,26)
|
||||
| InChIKey |
FZBJOVYOONJNIG-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [528996] | |
| Kappa-type opioid receptor | Target Info | Inhibitor | [528996] | ||
| Mu-type opioid receptor | Target Info | Inhibitor | [528996] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||